Specialty Pharmacy

SYDNEY — Australian drug maker QRxPharma is seeking approval for a drug that combines two painkillers in one pill, the company said Monday.

QRxPharma announced that it had filed a regulatory approval application with the Food and Drug Administration for MoxDuo IR (morphine and oxycodone). The drug is designed to release both drugs into the body immediately.

MAPLE GROVE, Minn. — Upsher-Smith Labs has started a late-stage clinical trial of a drug for treating patients with a rare and severe form of epilepsy, the drug maker said Monday.

LAKE MARY, Fla. — The Orlando, Fla., chapter of the Association for Corporate Growth has selected independent specialty pharmacy provider Axium Healthcare Pharmacy as the winner of one of its top awards.

ACG Orlando selected Axium as the recipient of the 2011 SMART Award in the Healthcare & Life Sciences category. ACG Orlando recognizes companies each year based on the value they bring to the region in terms of corporate culture, growth, business creativity and economic contribution.

NEW YORK — Taking drugs for treating HIV might reduce the risk of infection among heterosexual couples, according to two new studies conducted in Africa.

One study, funded by the Bill & Melinda Gates Foundation and conducted among 4,758 couples in Kenya and Uganda, found that when taken daily, Gilead’s Viread (tenofovir) reduced the rates of infection by at least 62% compared with placebo. Truvada (tenofovir and emtricitabine), another drug made by Gilead, reduced infection risk by 73%.

ST. LOUIS — Retail pharmacy and specialty distributor Foundation Care has acquired a new office and warehouse space to accommodate new demand for its pharmacy and distribution services, the company said.

The 20,000-sq.-ft. space is adjacent to its Earth City, Mo., location, and the company said it would ensure adequate space to cater to its current and future pharmaceutical, biotech and device business partners.

PLANEGG-MARTINSRIED, Germany — The Food and Drug Administration has granted orphan drug designation to a cancer treatment in mid-stage development made by German drug maker 4SC, the company said Tuesday.

4SC announced that it received the designation for resminostat, currently in phase-2 clinical trials as a treatment for hepatocellular cancer, or HCC. The FDA grants orphan drug designation to drugs for diseases that affect fewer than 200,000 people in the United States.

FLINT, Mich. — The country’s largest privately owned specialty pharmacy provider recently got a visit from the U.S. secretary of labor.

Diplomat Specialty Pharmacy announced last week that labor secretary Hilda Solis toured the company’s new headquarters at a former General Motors building in Flint, Mich.

“This is testimony of what people can do when they pull together,” Solis said, referring to Diplomat’s use of the building. “Flint, Mich., is on the map again.”

ALTAMONTE SPRINGS, Fla. — BioPlus Specialty Pharmacy has named Bill Cook VP sales, the company said.

Cook previously worked as SVP business development and sales at CareSouth and also has worked as VP sales at United Therapeutics, Accredo Health and Gentiva. In his new position with BioPlus, Cook will be responsible for the national sales force.